Microplastics (MPs) and nanoplastics have been an emerging global concern, with hazardous effects on plant, animal, and human health. Their small size makes it easier for them to spread to various ecosystems and enter the food chain; they are already widely found in aqueous environments and within aquatic life, and have even been found within humans. Much research has gone into understanding micro-/nanoplastic sources and environmental fate, but less work has been done to understand their degradation.
View Article and Find Full Text PDFGut-microbiota modulation shows promise in improving immune-checkpoint blockade (ICB) response; however, precision biomarker-driven, placebo-controlled trials are lacking. We performed a multicenter, randomized placebo-controlled, biomarker-stratified phase I trial in patients with ICB-naïve metastatic melanoma using SER-401, an orally delivered Firmicutesenriched spore formulation. Fecal microbiota signatures were characterized at baseline; patients were stratified by high versus low Ruminococcaceae abundance prior to randomization to the SER-401 arm (oral vancomycin-preconditioning/SER-401 alone/nivolumab + SER-401), versus the placebo arm [placebo antibiotic/placebo microbiome modulation (PMM)/nivolumab + PMM (NCT03817125)].
View Article and Find Full Text PDFPropylene production through propane dehydrogenation (PDH) is endothermic, and high temperatures required to achieve acceptable propane conversions lead to low selectivity and severe carbon-induced deactivation of conventional catalysts. We developed a catalyst-membrane system that removes the hydrogen by-product and can thus achieve propane conversions that exceed equilibrium limits. In this codesigned system, a silica/alumina (SiO/AlO) hollow-fiber hydrogen membrane was packed with a selective platinum-tin (PtSn/SiO) PDH catalyst on the tube side with hydrogen diffusing from the tube to the shell side.
View Article and Find Full Text PDF